Insulin-like growth factor receptor expression is associated with aggressive phenotypes and has therapeutic activity in biliary tract cancers-Reference-Cited by-同舟云学术

Insulin-like growth factor receptor expression is associated with aggressive phenotypes and has therapeutic activity in biliary tract cancers

Published:2011-12-13 Issue:2 Volume:103 Page:252-261
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:

Author:

Ohashi Hirokazu,Adachi Yasushi,Yamamoto Hiroyuki,Taniguchi Hiroaki,Nosho Katsuhiko,Suzuki Hiromu,Arimura Yoshiaki,Imai Kohzoh,Carbone David P.,Shinomura Yasuhisa

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2011.02138.x/fullpdf

Reference47 articles.

1. Carcinoma of the gallbladder;Misra;Lancet Oncol,2003

2. Cholangiocarcinoma;Lazaridis;Gastroenterology,2005

3. Biological characteristics of cancers in the gallbladder and biliary tract and targeted therapy;Thomas;Crit Rev Oncol Hematol,2007

4. Cancer of the gallbladder and extrahepatic bile ducts;Cleary;Curr Probl Surg,2007

5. Type I insulin-like growth factor receptor as a therapeutic target in cancer;Miller;Cancer Res,2005

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High Glucose Induced Upregulation of Cyclin a Associating with a Short Survival of Patients with Cholangiocarcinoma: A Potential Target for Treatment of Patients with Diabetes Mellitus;Nutrition and Cancer;2021-08-06

2. Obesity and cholangiocarcinoma: A review of epidemiological and molecular associations;Journal of Hepato-Biliary-Pancreatic Sciences;2021-06-17

3. Multifaceted Aspects of Metabolic Plasticity in Human Cholangiocarcinoma: An Overview of Current Perspectives;Cells;2020-03-03

4. Insulin-like Growth Factor-1, Insulin-like Growth Factor Binding Protein-3 and the Incidence of Malignant Neoplasms in a Nested Case–Control Study;Cancer Prevention Research;2020-01-29

5. Circulating insulin‐like growth factor binding protein‐3 and risk of gastrointestinal malignant tumors;Journal of Gastroenterology and Hepatology;2019-07-24